Beneficial Effects of Quinoa (Chenopodium Quinoa Willd) in the Prevention of Type 2 Diabetes Mellitus

Launched by INSTITUT D'INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER · Aug 25, 2020

Keywords

ClinConnect Summary

The study was a cross-over pilot clinical study consisting of two periods. The first period was only an observational and monitoring phase where participants just continued with their regular diet (RD), for this reason all participants initiated this period and wash-out term was no needed. Subsequently, with the data of the first phase obtained, the subjects began the second period in which they had to undergo a nutritional intervention with a quinoa diet (QD).

A total of six visits plus two quinoa products collection days were programmed. After the pre-study visit (V0) which took place a ...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Glucose levels between 100 and 125 mg/dL and without a previous diagnosis of diabetes
• Exclusion Criteria:
• * Do not consume a diet with daily presence of grains or cereals derivatives, tubers or/and legumes, or they presented any other health problem that the research staff considered contraindicated:
• • Treatment with oral antidiabetic drugs Chronic treatment with oral steroids and / or AINES Treatment with oral antidiabetic agents and / or insulin Treatment with immunosuppressive drugs Diagnosis of active neoplasm Diagnosis of HIV or AIDS Abnormal liver profile (\> 6 times normal values) Diagnosis of Acute Psychiatric Sdr Presence of serious acute concomitant disease, which it requires more than 7 days of recovery.
• • Major cardiovascular event (stroke, myocardial infarction) in the month prior to randomization.
• • Any other condition that the investigator considers to be inoperative so that the subject conducts the study.